×
For best experience we recommend to activate Javascript in your browser.
MAP2 antibody (AA 727-985)
This anti-MAP2 antibody is a Rabbit Polyclonal antibody detecting MAP2 in WB, ELISA, ICC, IHC (p) and IHC (fro). Suitable for Human.
Quick Overview for MAP2 antibody (AA 727-985) (ABIN7622484)
Target
See all MAP2 Antibodies
MAP2
(Microtubule-Associated Protein 2 (MAP2))
Reactivity
All reactivities for MAP2 antibodies
Human
Host
All hosts for MAP2 antibodies
Rabbit
Clonality
All clonalities for MAP2 antibodies
Polyclonal
Conjugate
All conjugates for MAP2 antibodies
This MAP2 antibody is un-conjugated
Application
All applications for MAP2 antibodies
Western Blotting (WB), ELISA, Immunocytochemistry (ICC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
Product Details anti-MAP2 Antibody
(hide)
Binding Specificity
All epitopes for MAP2 antibodies
AA 727-985
Purpose
Microtubule Associated Protein 2 (MAP2) Polyclonal Antibody
Sequence
Leu727~Asp985
Characteristics
The Microtubule Associated Protein 2 (MAP2) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, ICC, IHC-P, IHC-F, ELISA.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for MAP2
(hide)
Target
MAP2
(Microtubule-Associated Protein 2 (MAP2))
Alternative Name
MAP2
Gene ID
4133
UniProt
P11137
Recently viewed
(hide)
Chat with us , powered by LiveChat